Results 191 to 200 of about 286,705 (254)

Girard-Bourdieu

sociorel, 2013
openaire   +1 more source

Rare diseases load through the study of a regional population. [PDF]

PLoS Genet
Michel É, Moreau C, Gagnon L, Gagnon M, Leblanc J, Tardif J, Girard L, Mathieu J, Gagnon C, Desmeules M, Brisson JD, Bouchard L, Girard SL.   +12 more
europepmc   +1 more source

Specific host-algae relationship, yet flexible bacterial microbiome, in diatom-bearing foraminifera. [PDF]

Sci Adv
Girard EB, Del Rio-Hortega L, Pratama AMA, Volkenandt S, Macher JN, Wilken S, Renema W.   +6 more
europepmc   +1 more source

Real-life use of bone-targeting agents for bone metastases in France between 2009 and 2018: Results of the OPTIMOS study. [PDF]

J Bone Oncol
Confavreux CB, Bouvard B, Girard N, Bosco-Levy P, Marchal C, Nolin M, Lehmann E, Desameric G, Belhassen M.   +8 more
europepmc   +1 more source

Historical Use of Markov Model and Posterior Predictive Checks in Pharmacometrics. [PDF]

CPT Pharmacometrics Syst Pharmacol
Girard P, Kastrissios H.
europepmc   +1 more source

Maximizing Extubation Outcomes Through Educational and Organizational Research (METEOR) Trial: protocol for a batched, stepped-wedge, cluster-randomised, type 2 hybrid effectiveness-implementation trial. [PDF]

BMJ Open
Prendergast NT, Kahn JM, Angus DC, Argote L, Barnes B, Chang CH, Graff S, Hess DR, Onyemekwu CA, Rak KJ, Russell JL, Seaman JB, Toth KM, Girard TD.   +13 more
europepmc   +1 more source